SpectraCure
1.776
SEK
0 %
Less than 1K followers
SPEC
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
0%
-5.13%
-29.66%
-30.22%
-6.33%
-31.03%
-80.63%
-91.29%
+21.03%
SpectraCure is a medical technology company The company specializes in the research and development of medical technology systems used to treat prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internally solid tumors of various types. The company operates in the Nordic market. The head office is located in Lund.
Read moreMarket cap
172.51M SEK
Turnover
91.93K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
15.5
2025
General meeting '25
15.5
2025
Interim report Q1'25
15.8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
A well-accomplished annual audit in accordance with ISO 13485:2016
Expert group comments on results of ongoing study
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools